|Videos|May 8, 2023
Interview with Bormioli Pharma’s Andrea Lodetti at DCAT
Author(s)Bormioli Pharma
Key Learning Objectives
- Italy’s Bormioli Pharma grew North American sales of its leading glass and plastic packaging for injectable drugs by 40% in 2022 while mobilizing a multimillion dollar investment program to expand its parental drug packaging solutions
- Celebrating its 200th anniversary, the company is pursuing ambitious “50-in-5” sustainability goals and commitments to alleviate industry supply chain shortages
- Bormioli Pharma supplies customers with complete packaging solutions, including innovative glass and plastic bottles; plastic, rubber and aluminum closures; and accessories
Related Content
Trending on Pharmaceutical Technology
1
Technology Transfer: Success Drivers and Obstacles Explained
2
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
3
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
4
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
5